Ann M Vuong1, Glenys M Webster2, Kimberly Yolton3, Antonia M Calafat4, Gina Muckle5, Bruce P Lanphear2, Aimin Chen6. 1. Department of Epidemiology and Biostatistics, School of Public Health, University of Nevada, Las Vegas, Las Vegas, NV, USA. Electronic address: ann.vuong@unlv.edu. 2. BC Children's Hospital Research Institute and Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada. 3. Division of General and Community Pediatrics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 4. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 5. School of Psychology, Laval University, Québec, Québec, Canada. 6. Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Abstract
BACKGROUND: Studies of prenatal per- and polyfluoroalkyl substances (PFAS) and attention deficit hyperactivity disorder (ADHD)-related behaviors in children are inconsistent. OBJECTIVES: To examine associations between maternal serum PFAS concentrations and child behavior in 241 mother-child dyads within the Health Outcomes and Measures of the Environment (HOME) Study. METHODS: We quantified perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), and perfluorononanoate (PFNA) in maternal serum collected during pregnancy or at delivery. We evaluated a total of 17 outcomes of child behavior using the Behavioral Assessment System for Children-2 (BASC-2) at 5 and 8 years (n = 240) and ADHD diagnostic symptoms and criteria with the Diagnostic Interview Schedule for Children-Young Child (DISC-YC) at 5 years (n = 190). We used linear mixed models and logistic regression with generalized estimating equations to assess associations between PFAS and continuous or dichotomous "at risk" BASC-2 scores; negative binomial regression to calculate incident rate ratios for counts of ADHD symptoms; and Poisson regression with robust standard errors to calculate relative risks of meeting ADHD diagnostic criteria. RESULTS: Each ln-unit increase in PFOS, PFHxS, and PFNA was associated with higher BASC-2 scores and increased odds of "at-risk" scores for externalizing behaviors, including hyperactivity (PFOS: odds ratio [OR] 2.7, 95% confidence interval [CI] 1.2, 5.9; PFHxS: OR 2.5, 95% CI 1.5, 4.3; PFNA: OR 3.2, 95% CI 1.3, 8.0). PFHxS was also associated with internalizing problems (OR 2.0, 95% CI 1.1, 3.4) and somatization (OR 2.2, 95% CI 1.2, 4.0). PFOS and PFNA were significantly associated with 50-80% more DISC-YC symptoms and diagnostic criteria related to hyperactive-impulsive type ADHD. Prenatal PFNA was associated with increased risk of any-type ADHD. CONCLUSIONS: Prenatal PFOS and PFNA were consistently associated with measures related to hyperactive-impulsive type ADHD across two validated assessment instruments. PFHxS was associated with increased problems with both externalizing and internalizing behaviors. No associations were noted between PFOA and child neurobehavior.
BACKGROUND: Studies of prenatal per- and polyfluoroalkyl substances (PFAS) and attention deficit hyperactivity disorder (ADHD)-related behaviors in children are inconsistent. OBJECTIVES: To examine associations between maternal serum PFAS concentrations and child behavior in 241 mother-child dyads within the Health Outcomes and Measures of the Environment (HOME) Study. METHODS: We quantified perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), and perfluorononanoate (PFNA) in maternal serum collected during pregnancy or at delivery. We evaluated a total of 17 outcomes of child behavior using the Behavioral Assessment System for Children-2 (BASC-2) at 5 and 8 years (n = 240) and ADHD diagnostic symptoms and criteria with the Diagnostic Interview Schedule for Children-Young Child (DISC-YC) at 5 years (n = 190). We used linear mixed models and logistic regression with generalized estimating equations to assess associations between PFAS and continuous or dichotomous "at risk" BASC-2 scores; negative binomial regression to calculate incident rate ratios for counts of ADHD symptoms; and Poisson regression with robust standard errors to calculate relative risks of meeting ADHD diagnostic criteria. RESULTS: Each ln-unit increase in PFOS, PFHxS, and PFNA was associated with higher BASC-2 scores and increased odds of "at-risk" scores for externalizing behaviors, including hyperactivity (PFOS: odds ratio [OR] 2.7, 95% confidence interval [CI] 1.2, 5.9; PFHxS: OR 2.5, 95% CI 1.5, 4.3; PFNA: OR 3.2, 95% CI 1.3, 8.0). PFHxS was also associated with internalizing problems (OR 2.0, 95% CI 1.1, 3.4) and somatization (OR 2.2, 95% CI 1.2, 4.0). PFOS and PFNA were significantly associated with 50-80% more DISC-YC symptoms and diagnostic criteria related to hyperactive-impulsive type ADHD. Prenatal PFNA was associated with increased risk of any-type ADHD. CONCLUSIONS: Prenatal PFOS and PFNA were consistently associated with measures related to hyperactive-impulsive type ADHD across two validated assessment instruments. PFHxS was associated with increased problems with both externalizing and internalizing behaviors. No associations were noted between PFOA and child neurobehavior.
Authors: Joseph M Braun; Geetika Kalloo; Aimin Chen; Kim N Dietrich; Stacey Liddy-Hicks; Samantha Morgan; Yingying Xu; Kimberly Yolton; Bruce P Lanphear Journal: Int J Epidemiol Date: 2017-02-01 Impact factor: 7.196
Authors: Birgit Bjerre Høyer; Cecilia Høst Ramlau-Hansen; Carsten Obel; Henning Sloth Pedersen; Agnieszka Hernik; Victor Ogniev; Bo A G Jönsson; Christian H Lindh; Lars Rylander; Anna Rignell-Hydbom; Jens Peter Bonde; Gunnar Toft Journal: Environ Health Date: 2015-01-07 Impact factor: 5.984
Authors: Theodore A Slotkin; Emiko A MacKillop; Ronald L Melnick; Kristina A Thayer; Frederic J Seidler Journal: Environ Health Perspect Date: 2008-06 Impact factor: 9.031
Authors: Ann M Vuong; Kimberly Yolton; Changchun Xie; Kim N Dietrich; Joseph M Braun; Glenys M Webster; Antonia M Calafat; Bruce P Lanphear; Aimin Chen Journal: Neurotoxicol Teratol Date: 2021-08-24 Impact factor: 3.763
Authors: Allison Kupsco; Jenny Jyoung Lee; Diddier Prada; Damaskini Valvi; Lisa Hu; Maria Skaalum Petersen; Brent A Coull; Pal Weihe; Philippe Grandjean; Andrea A Baccarelli Journal: Environ Int Date: 2021-11-20 Impact factor: 13.352
Authors: Yun Liu; Melissa N Eliot; George D Papandonatos; Karl T Kelsey; Ruby Fore; Scott Langevin; Jessie Buckley; Aimin Chen; Bruce P Lanphear; Kim M Cecil; Kimberly Yolton; Marie-France Hivert; Sharon K Sagiv; Andrea A Baccarelli; Emily Oken; Joseph M Braun Journal: Environ Health Perspect Date: 2022-03-10 Impact factor: 11.035
Authors: Andrea B Kirk; Kelsey Marie Plasse; Karli C Kirk; Clyde F Martin; Gamze Ozsoy Journal: Int J Environ Res Public Health Date: 2022-07-09 Impact factor: 4.614